small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube

Insights & News

Professionals
Capabilities: Services
Capabilities: Sectors
Capabilities: Regions
Type
Offices
Start Date
End Date

Get Our Updates

Subscribe
View:
Client Alert
Key California Labor and Employment Updates for 2026

January 13, 2026

Blog
Prospective Tariffs on Metals, Computer Chips, Semiconductors, and Pharmaceuticals

January 29, 2025

Article
Key Corporate Governance Strategies for Mitigating AI-related Legal Risks in the Pharmaceutical Industry

September 4, 2024

In the Media
Dan Webb Discusses Illustrious Career and Ability to Try a Large Caseload with Chicago Sun-Times

August 28, 2023

Recognitions
Winston & Strawn Recognized in 2023 Leaders League Healthcare, Pharmaceuticals & Biotech Rankings

July 24, 2023

Speaking Engagement
Kurt Mathas Speaks on Pharmaceutical Patent Litigation Settlements at Paragraph IV Disputes Conference

April 19-20, 2023

Blog
FTC and DOJ Workshop on Pharmaceutical Mergers Highlights Potential for Heightened Scrutiny by Enforcers

July 6, 2022

Client Alert
Federal Circuit Limits Pharmaceutical Claim Construction Because of Prosecution History and Written Description

February 17, 2022

Client Alert
Carving Out a Patented Indication from a Generic-Pharmaceutical Label Will Not Always Avoid Infringement

September 7, 2021

Blog
FTC’s New International Working Group Signals Closer Scrutiny of Pharmaceutical Mergers

March 30, 2021

Client Alert
FDA Announces Innovative Quality Management Maturity Pilot Programs for Manufacturers of Drug Products and Active Pharmaceutical Ingredients

October 21, 2020

Speaking Engagement
Winston Partners Speak at The 17th Annual Pharmaceutical Compliance Congress

August 10-14, 2020

Blog
Petition for Certiorari Seeks Clarification of Preemption Analysis in Pharmaceutical Failure-to-Warn Cases

July 15, 2020

Client Alert
Patent Term Extension Under 35 U.S.C. § 156 Covers an Active Pharmaceutical Ingredient—Including Any Salt or Ester of the Active Ingredient—but Does Not Encompass a Metabolite of the Active Ingredient or Its De-Esterified Form

April 21, 2020

Recognitions
Winston & Strawn Recognized in Décideurs 2019 Guide to Health, Pharmaceuticals, and Biotechnology

January 15, 2020

Client Alert
Sun Capital Funds Withdrawn from Withdrawal Liability: First Circuit Court of Appeals

December 4, 2019

News
Winston Attorneys Author Chapter in Chambers Global Pharmaceutical Advertising Practice Guide

March 12, 2019

Blog
ITC Complainant Throws a Wrinkle in Korean Pharmaceutical’s Bid to Introduce New Botox Product into the U.S.

March 7, 2019

  • 1
  • 2
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising